GPCR
Structure Therapeutics
GPCR • NASDAQ
Structure Therapeutics is a pharmaceutical preparations company trading on NASDAQ, led by CEO Raymond C. Stevens.
CEORaymond C. Stevens
Next Earnings
Upcoming earnings announcement for Structure Therapeutics
Date
Thursday, May 7, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.34
Revenue Estimate
$12.5M
Earnings History
Past 10 earnings reports for Structure Therapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 26, 2026 | Q4 2025 | -$0.36Est: -$0.36 | 0.0% | -Est: $200.0M | -100.0% |  10-K |
| Nov 6, 2025 | Q3 2025 | -$0.37Est: -$0.36 | -2.8% | - | — | 10-Q |
| Aug 6, 2025 | Q2 2025 | -$0.36Est: -$0.33 | -9.1% | - | — | 10-Q |
| May 8, 2025 | Q1 2025 | -$0.27Est: -$0.23 | -17.4% | - | — | 10-Q |
| Feb 27, 2025 | Q4 2024 | -$0.22Est: -$0.17 | -29.4% | - | — | 10-K |
| Nov 13, 2024 | Q3 2024 | -$0.20Est: -$0.20 | 0.0% | - | — | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.18Est: -$0.23 | +21.7% | - | — | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.19Est: -$0.21 | +9.5% | - | — | 10-Q |
| Mar 8, 2024 | Q4 2023 | -$0.16Est: -$0.21 | +23.8% | - | — | 10-K |
| Nov 14, 2023 | Q3 2023 | -$0.21Est: -$0.29 | +27.6% | - | — | — |